Virginia Retirement Systems’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.9M | Hold |
25,474
| – | – | 0.09% | 191 |
|
|
2026
Q1 | $19.7M | Sell |
25,474
-16,240
| -39% | -$12.4M | 0.15% | 173 |
|
|
2025
Q4 | $32.2M | Sell |
41,714
-11,340
| -21% | -$7.7M | 0.19% | 131 |
|
|
2025
Q3 | $29.8M | Hold |
53,054
| – | – | 0.19% | 125 |
|
|
2025
Q2 | $27.9M | Sell |
53,054
-50,000
| -49% | -$27.9M | 0.19% | 137 |
|
|
2025
Q1 | $65.4M | Buy |
+103,054
| New | +$70.9M | 0.49% | 52 |
|
|
2023
Q3 | $106M | Buy |
128,454
+12,500
| +11% | +$9.82M | 1.04% | 12 |
|
|
2023
Q2 | $83.3M | Buy |
115,954
+11,300
| +11% | +$8.71M | 0.8% | 23 |
|
|
2023
Q1 | $86M | Buy |
104,654
+29,554
| +39% | +$22.3M | 0.89% | 18 |
|
|
2022
Q4 | $54.2M | Buy |
75,100
+7,500
| +11% | +$5.53M | 0.56% | 38 |
|
|
2022
Q3 | $46.6M | Buy |
+67,600
| New | +$42.5M | 0.53% | 45 |
|
|
2022
Q1 | $61.4M | Sell |
87,900
-31,700
| -27% | -$20.1M | 0.57% | 32 |
|
|
2021
Q4 | $75.5M | Hold |
119,600
| – | – | 0.52% | 28 |
|
|
2021
Q3 | $72.4M | Sell |
119,600
-7,500
| -6% | -$4.66M | 0.74% | 21 |
|
|
2021
Q2 | $71M | Sell |
127,100
-200
| -0.2% | -$101K | 0.7% | 25 |
|
|
2021
Q1 | $60.2M | Buy |
127,300
+7,000
| +6% | +$3.41M | 0.59% | 42 |
|
|
2020
Q4 | $58.1M | Buy |
120,300
+4,500
| +4% | +$2.43M | 0.61% | 38 |
|
|
2020
Q3 | $64.8M | Buy |
115,800
+14,400
| +14% | +$8.73M | 0.74% | 27 |
|
|
2020
Q2 | $63.2M | Buy |
101,400
+39,800
| +65% | +$22.6M | 0.75% | 24 |
|
|
2020
Q1 | $30.1M | Buy |
61,600
+18,100
| +42% | +$7.47M | 0.41% | 54 |
|
|
2019
Q4 | $16.3M | Hold |
43,500
| – | – | 0.18% | 158 |
|
|
2019
Q3 | $12.1M | Sell |
43,500
-13,000
| -23% | -$3.85M | 0.14% | 194 |
|
|
2019
Q2 | $17.7M | Sell |
56,500
-38,300
| -40% | -$12.8M | 0.2% | 145 |
|
|
2019
Q1 | $38.9M | Buy |
94,800
+39,400
| +71% | +$16.2M | 0.46% | 46 |
|
|
2018
Q4 | $20.7M | Buy |
55,400
+4,500
| +9% | +$1.65M | 0.28% | 102 |
|
|
2018
Q3 | $20.6M | Buy |
50,900
+14,500
| +40% | +$5.52M | 0.24% | 113 |
|
|
2018
Q2 | $12.6M | Sell |
36,400
-25,700
| -41% | -$8.04M | 0.15% | 182 |
|
|
2018
Q1 | $21.4M | Buy |
62,100
+13,300
| +27% | +$4.63M | 0.26% | 115 |
|
|
2017
Q4 | $18.3M | Buy |
48,800
+20,300
| +71% | +$8.22M | 0.22% | 133 |
|
|
2017
Q3 | $12.7M | Sell |
28,500
-16,100
| -36% | -$7.66M | 0.16% | 191 |
|
|
2017
Q2 | $21.9M | Buy |
44,600
+3,300
| +8% | +$1.44M | 0.27% | 109 |
|
|
2017
Q1 | $16M | Buy |
41,300
+24,100
| +140% | +$8.93M | 0.21% | 144 |
|
|
2016
Q4 | $6.31M | Buy |
+17,200
| New | +$6.54M | 0.09% | 280 |
|
|
2015
Q4 | $22.8M | Sell |
41,922
-578
| -1% | -$313K | 0.34% | 84 |
|
|
2015
Q3 | $19.8M | Buy |
42,500
+13,926
| +49% | +$7.48M | 0.3% | 96 |
|
|
2015
Q2 | $14.6M | Buy |
28,574
+1,913
| +7% | +$934K | 0.22% | 141 |
|
|
2015
Q1 | $12M | Buy |
26,661
+22,930
| +615% | +$9.72M | 0.18% | 179 |
|
|
2014
Q4 | $1.53M | Sell |
3,731
-3,096
| -45% | -$1.22M | 0.02% | 395 |
|
|
2014
Q3 | $2.46M | Buy |
6,827
+5,230
| +327% | +$1.75M | 0.04% | 317 |
|
|
2014
Q2 | $451K | Buy |
1,597
+17
| +1% | +$5.04K | 0.01% | 715 |
|
|
2014
Q1 | $474K | Buy |
1,580
+597
| +61% | +$184K | 0.01% | 681 |
|
|
2013
Q4 | $271K | Buy |
983
+241
| +32% | +$69.3K | 0.01% | 760 |
|
|
2013
Q3 | $232K | Sell |
742
-1,657
| -69% | -$436K | 0.01% | 762 |
|
|
2013
Q2 | $539K | Buy |
+2,399
| New | +$559K | 0.01% | 634 |
|
Other funds holding REGN
Virginia Retirement Systems's REGN Position: Q2 2026 in Review
Virginia Retirement Systems held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 25,474 shares worth $15.9M. The position accounts for 0.09% of the portfolio, ranked #191.
Virginia Retirement Systems first reported a position in REGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $106M in Q3 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Virginia Retirement Systems held 25,474 shares of Regeneron Pharmaceuticals worth $15.9M as of Q2 2026.
- Virginia Retirement Systems left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.09% of Virginia Retirement Systems's portfolio in Q2 2026, its #191 holding.
- Virginia Retirement Systems first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
- Virginia Retirement Systems's Regeneron Pharmaceuticals position peaked at $106M in Q3 2023.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.